Exercise in Parkinson s the new drug

Size: px
Start display at page:

Download "Exercise in Parkinson s the new drug"

Transcription

1 Exercise in Parkinson s the new drug Bhanu Ramaswamy MCSP 19th/20th March 2010 ACPIN Residential Conference Fit for Life? Exercise and Neurology Northampton

2 Aims; no particular order & simple Augment the Spring Conference Key Note lectures (icsp soon!) To consider how cellular biology and animalmodel research are increasing evidence. Translate the information into a framework for exercise and Parkinson s Intersperse with discussion on the Parkinsonian relevancies of emerging evidence that might influence clinical practice Briefly consider what might sustain habits and interest in exercise for people with Parkinsonism

3 100% Causative factor Neurorestoration NICE CG 35 (2006) Dopaminergic neurones Treatment commenced Neurorescue Neuroprotection Time

4 Exercise at molecular level Two-fold effect by up-regulating brain-derived neurotrophic factor. 1. Facilitates synaptic function by increasing plasticity in injured CNS and spinal cord to and promotes neuronal repair 2. Maintains neural function by neurotrophic support enhancing learning and memory So exercise may be powerful in augmenting synaptic plasticity, promoting behavioural rehabilitation, and counteracting the deleterious effects of aging. (Vaynman and Gomez-Pinilla (2005) Neurorehabilitation and Neural Repair 19 (4)

5 Animal models (Petzinger, Zigmond, Fisher) Mice, rats, rabbits, gerbils & primates Lesion the animal (induce Parkinson s), experiment, euthanise then investigate! 1. Studies in rodent models (rats and mice love to run 9 hours / day!) provide positive effects on dopaminergic neurotransmission. 2. Forced exercise (forced to maintain running speed greater than preferred pace), usually treadmill, improves motor function and is neuroprotective in Parkinsonian-treated animals 3. Modulate genes and proteins important to basal ganglia function

6 What of pre-disease state? If regular (intense) exercise can protect the brain and improve the capacity for self-repair, the hypothesis is that damage can be reduced by prior motor training So exercise animals hard (forced exercise), review the neuro-protective effects of motor exercise using a chemical that would normally destroy dopamine neurons. In exercised animals, the vulnerability of dopamine neurons were reduced with less dramatic effect to nervous system (Smith and Zigmond 2003 Experimental Neurology 184 (1) 31-39)

7 Person perspective of benefits Sheffield PD Class cohort 2006 It makes me feel I can maximise my (physical) potential Allows me to remain fit (and possibly healthy) Limits dependence on my spouse Gives me freedom am back driving, shopping unsupervised, arm less painful

8 Therapeutic expectation Minimise effects of disease progression (neuroprotection) Physiological effects (increased dopamine levels, endurance, flexibility, balance ) Functional status outcomes (increased stride length, distances, independence) Psychological (stress levels, well-being) Social (involvement and support)

9 Strength examples and variety Dibble 2009, 2006 ergometer resistance and intensity (Ellis 2005 general rehabilitation) Hirsch 2003, 1996 balance and resistance Scandalis 2001 lower limb weights Toole 2000 balance and strength (Reuter 1999 gym and pool) (Bridgewater trunk-specific aerobics) N.B. (Brackets indicate programmes for which strength was one part but not the main outcome of the sessions)

10 Yoga (Discursive) Tai Chi (Lee et al 2008 critical review, Hackney 2008, Li et al 2007 pilot,) Dance Tango (Hackney and Earhart ) Argentinean tango better than ballroom plus paired better than non-paired Exercise styles

11 Lifestyles and PD Conductive education Bandyopadhyay et al 2002, Yekutiel et al 1991 Pilates - none Alexander technique Stallibrass 2002, 1997

12 Relevancies 1: BG dysfunction Impaired performance of well learned motor skills and movement sequences Problems maintaining sufficient movement amplitudes (sensori-motor feedback) Difficulty performing two or more well learned tasks simultaneously Difficulty shifting motor and cognitive sets Increased time for mental processing

13 Relevancies 2: Classifications 1. Primary (idiopathic) parkinsonism Secondary (acquired, symptomatic) + 3. Heredodegenerative parkinsonism 4. Multiple system degeneration (parkinsonism plus syndromes). Features, such as tremor, early gait abnormality (e.g. freezing), postural instability, non-motor and response to levodopa, can be used to differentiate PD from other parkinsonian disorders. Jankovic 2008

14 Relevancies 3: Subtypes Variable course of progression and symptom implies different biochemical or degenerative mechanisms. Early disease onset (25%) longest duration till death, delay before falls and cognitive decline Tremor dominant (31%) same life expectancy, falls history and hallucinations as non-tremor dom Non-tremor dominant (36%) strong association with cognitive impairment (Lewy body pathology) Rapid disease progression without dementia (8%) older, early depression, midline symptoms, often tremulous onset, increased mentation, freezing and ADL (UPDRS Part I and II) subscores (Selikhova et al 2009 Brain;132(11); ; Schrag et al 2008 Mov Disord 22(7) ; Jancovic and Kapadia (2001) Arch Neurol; 58: )

15 Relevancies 4: Dual tasking Clinical debate re: multi-, dual- & uni-tasking Shown to slow responses RESCUE studies (Rochester et al 2007 Journal of Neural Transmission 114 (10) ) Bradykinesia main culprit. Difficulty in self-pacing, reaction time prolonged & abnormal pre-movement EEG, sensory scaling and sensorimotor integration. If use compensation strategy (cue), engagement of processes further reduces other task performance Response to L-dopa treatments or cues decreases Surgery a possible solution e.g. bilateral subthalamic nucleus stimulation. Might remove interfering signals; more efficient compensation by other cortical mechanisms, especially postural control. Schrag et al 2008 Mov Disord 22(7) ; Maurer et al 2003 Brain 126 (5)

16 Relevancies 5: Freezing Macht et al 2007 Mov Disord 22(7) Freezing is significantly associated with longer disease duration and advanced stage of the disease.? Relation with dualtasking Freezing episodes more likely in men than in women and in patients taking, in addition to levodopa, Entacapone, Amantadine, or dopamine agonists. Less common in tremor-dominant Different response on / off

17 In summary From animal (and some human) models: Exercise is beneficial BUT for neuroprotection and possibly rescue the F.I.T. principles must be higher (60% MHR) than currently undertaken Only evidenced as modifiable in early disease or new onset (traumatic) if hope for rescue element Specifically targeted and reward driven Complexity to be considered to utilise wider brain function. Hirsch M, Farley BG Eur J Phys Rehabil Med 45(2) )

18 Possible symptomatic framework Brady / hypokinesia flexibility, then speed, amplitude and sensory Rigidity flexibility and rotatory action Tremor nil specific; as a consequence of upper limb weight bearing activities Postural instability - extensor activity and postural activation of agonoist/antag Freezing decrease speed, find overiding cue?

19 Condition stage Clinical model not considered in full Targeted exercise (earlier stage) Cued exercise (later stage) (See Nieuwboer Spring Conference Key note lecture) F.I.T.T principles Frequency Intensity Time (duration) Type

20 F.I.T.T principles (ACE & PD literature) IDEAL Frequency Intensity Time (duration) Type Endurance Start 2 3 x week for 3 months, then decrease to weekly 68 80%* MHR. Higher intensity if less frequent *Neuroprotect. Incremental increase to 150 mins / week (aim for mins sessions) Power walk, Treadmill, Nordic walk, run, cycle (group) Flexibility & posture Part of warm up each time exercise is undertaken Up to 5 major body areas selective if to work specifics 10 sec before and 30 sec stretch after session Separate stretch or part of increased amplitude exs Strength 2-3 x week 5 12 reps for 5 10 major m/s groups (10 rep max; large groups before small) Not as important as rest necessary according to state of muscles Free weights, body weights, machines, hydrotherapy, cycle

21 Finally, additional considerations Current fitness Consider a diary for accuracy and monitor progress Medication cycle and disease stage Use of enhancing cues / cueing strategies Appropriate environment Adherence (10 30% in trials) Sustain through longer term education = behavioural change Motivation = Choice, support and reward Transport and toilets = impede enjoyment Enjoyment = groups Fit lifestyle

The following are Alison Williams' notes on these topics, augmented by her comments on two lectures on the same themes. For the original lectures go to: https://events.qwikcast.tv/public/qwikcast/qwikcastevent?eventkey=1a1dbe73-e2f2-4945-9470-143f3f641805

More information

PD ExpertBriefing: The Effects of Exercise on PD

PD ExpertBriefing: The Effects of Exercise on PD PD ExpertBriefing: The Effects of Exercise on PD Led By: Margaret Schenkman, P.T., Ph.D., F.A.P.T.A. Associate Dean for Physical Therapy Education, and Director, Physical Therapy Program, University of

More information

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

MAXIMIZING FUNCTION IN PARKINSON S DISEASE 1 MAXIMIZING FUNCTION IN PARKINSON S DISEASE September 13, 2016 End Falls This Falls Conference Jan Goldstein Elman One Step Ahead Mobility Toronto, Ontario Outline An overview of Parkinson s disease (PD):

More information

PD AND FALLS J U MALLYA FALLS AWARENESS MEETING

PD AND FALLS J U MALLYA FALLS AWARENESS MEETING PD AND FALLS J U MALLYA FALLS AWARENESS MEETING 23-09-2016 PD Chronic Progressive neurodegenerative disease Motor system disorder Degeneration of Dopaminergic neurons in Substantia nigra in the midbrain.

More information

Robert Alan Bonakdar MD FAAFP Director of Pain Management Scripps Center for Integrative Medicine

Robert Alan Bonakdar MD FAAFP Director of Pain Management Scripps Center for Integrative Medicine Integrative Medicine in Parkinson s Disease (PD) Robert Alan Bonakdar MD FAAFP Director of Pain Management Scripps Center for Integrative Medicine 858 554 3300 Integrative Medicine in Parkinson s Disease

More information

Pushing the plasticity: The role of exercise in the management of neurological illness

Pushing the plasticity: The role of exercise in the management of neurological illness Pushing the plasticity: The role of exercise in the management of neurological illness Michael Gaetz Ph.D. Associate Professor, Kinesiology Department Faculty of Health Sciences University of the Fraser

More information

EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS

EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS INSIDE THIS GUIDE EXERCISE FOR PARKINSON S OVERVIEW 3 RECOMMENDATIONS FOR EXERCISE FOR PARKINSON S 4 EXERCISE FOR PARKINSON S PRINCIPLES 5

More information

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH PARKINSON'S DISEASE PD is a progressive neurological disease resulting

More information

Research Symposium Update on Exercise in Parkinson Disease

Research Symposium Update on Exercise in Parkinson Disease Research Symposium Update on Exercise in Parkinson Disease Terry Ellis, PT, PhD, NCS Director: Center for Neurorehabilitation Boston University 5/25/2017 Exercise Goals Slow Progression of Disease? Slow

More information

Postural instability Hypokinesia Rigidity Tremor Forward flexed posture. pain million people 50+ years old 10 most populated countries

Postural instability Hypokinesia Rigidity Tremor Forward flexed posture. pain million people 50+ years old 10 most populated countries 4.1-4.6 million people 50+ years old 10 most populated countries Cyndi Robinson, PT, PhD University of Washington Seattle, Washington, USA Progressive neurodegenerative disorder Selective neuronal loss

More information

Identifying the Types of Physical Exercise that Help Individuals with Parkinson s Disease Manage Their Symptoms: A Modified Delphi Study

Identifying the Types of Physical Exercise that Help Individuals with Parkinson s Disease Manage Their Symptoms: A Modified Delphi Study St. Cloud State University therepository at St. Cloud State Culminating Projects in Kinesiology Department of Kinesiology 6-2016 Identifying the Types of Physical Exercise that Help Individuals with Parkinson

More information

Moving fast or moving slow: an overview of Movement Disorders

Moving fast or moving slow: an overview of Movement Disorders Moving fast or moving slow: an overview of Movement Disorders Mini Medical School October 25, 2018 Heather Rigby, MD, FRCPC 2014 MFMER slide-1 2014 MFMER slide-2 Basal Ganglia Dysfunction - Movement Disorders

More information

LSVT BIG. Paula McGinley Senior Occupational Therapist

LSVT BIG. Paula McGinley Senior Occupational Therapist LSVT BIG Paula McGinley Senior Occupational Therapist LEARNING OBJECTIVES Have an understanding of: What is LSVT BIG How LSVT BIG differs from traditional PD therapy approach Importance of skill acquisition

More information

EXERCISE FREQUENCY AND PHYSICAL FUNCTION IN PARKINSON S DISEASE

EXERCISE FREQUENCY AND PHYSICAL FUNCTION IN PARKINSON S DISEASE Bulletin of the Transilvania University of Braşov Series IX: Sciences of Human Kinetics Vol. 9 (58) No. 2-2016 EXERCISE FREQUENCY AND PHYSICAL FUNCTION IN PARKINSON S DISEASE M. C. CACIULA 1 M. HORVAT

More information

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD Parkinson s Disease Foundation PD ExpertBriefing: Managing the Motor Symptoms in PD Led By: Sotirios A. Parashos, M.D. Minneapolis Clinic of Neurology and Struthers Parkinson's Center This session was

More information

Analysis of the Effects of Exercise on Parkinson's Disease

Analysis of the Effects of Exercise on Parkinson's Disease Analysis of the Effects of Exercise on Parkinson's Disease Item Type text; Electronic Thesis Authors Fallahi, Sara Publisher The University of Arizona. Rights Copyright is held by the author. Digital access

More information

III./3.1. Movement disorders with akinetic rigid symptoms

III./3.1. Movement disorders with akinetic rigid symptoms III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.

More information

Management of balance and gait in older individuals with Parkinson's disease

Management of balance and gait in older individuals with Parkinson's disease Washington University School of Medicine Digital Commons@Becker Physical Therapy Faculty Publications Program in Physical Therapy 2011 Management of balance and gait in older individuals with Parkinson's

More information

Texto proveniente de: ACSM s Certified News

Texto proveniente de: ACSM s Certified News Texto proveniente de: ACSM s Certified News Parkinson s Disease Etiology, Clinical Characteristics and the role of Exercise. By Yuri Feito, M.S., M.P.H., RCEP Department of Exercise, Sport and Leisure

More information

Parkinson s Disease. Sirilak yimcharoen

Parkinson s Disease. Sirilak yimcharoen Parkinson s Disease Sirilak yimcharoen EPIDEMIOLOGY ~1% of people over 55 years Age range 35 85 years peak age of onset is in the early 60s ~5% of cases characterized by an earlier age of onset (typically

More information

PWR!Moves Therapist Training and Certification Workshop

PWR!Moves Therapist Training and Certification Workshop PWR!Moves Therapist Training and Certification Workshop Date August 11-12, 2018 Location HealthSouth Hamarville Rehabilitation Hospital 320 Guys Run Rd Pittsburgh, PA 15238 Eligible Participants Physical/Occupational

More information

Balance and Falls in PD: Effective Interventions and Assistive Devices

Balance and Falls in PD: Effective Interventions and Assistive Devices Balance and Falls in PD: Effective Interventions and Assistive Devices Hanan Khalil, PhD Department of Rehabilitation Sciences Jordan University of Science and Technology Irbid, Jordan hwkhalil8@just.edu.jo

More information

Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Rehabilitation Services

Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Rehabilitation Services Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Katie Parafinczuk PT, DPT, NCS Redwood City, CA Rehabilitation Services My Background Kathleen.n.parafinczuk@kp.org

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:

More information

Evaluation and Management of Parkinson s Disease in the Older Patient

Evaluation and Management of Parkinson s Disease in the Older Patient Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of

More information

Faculty. Joseph Friedman, MD

Faculty. Joseph Friedman, MD Faculty Claire Henchcliffe, MD, DPhil Associate Professor of Neurology Weill Cornell Medical College Associate Attending Neurologist New York-Presbyterian Hospital Director of the Parkinson s Institute

More information

Exercise, Physical Therapy and Fall Prevention

Exercise, Physical Therapy and Fall Prevention Exercise, Physical Therapy and Fall Prevention University of Davis Medical Center Rosy Chow Neuro Clinical Specialist Physical Therapist Outline of Talk Role of Physical Therapy in care of people with

More information

Margaret Schenkman, PT, PhD, FAPTA University of Colorado, Denver Colorado

Margaret Schenkman, PT, PhD, FAPTA University of Colorado, Denver Colorado Margaret Schenkman, PT, PhD, FAPTA University of Colorado, Denver Colorado Present a framework for clinical reasoning with emphasis on Patient centered care Application of enablement and disablement frameworks

More information

Can Tango Help Improve Quality of Life for Patients with Parkinson s Disease?

Can Tango Help Improve Quality of Life for Patients with Parkinson s Disease? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Can Tango Help Improve Quality of Life

More information

Purpose of Physiotherapy

Purpose of Physiotherapy What role does physiotherapy play in the management of PD? Lynn Rochester PhD, Grad Dip Phys Professor of Human Movement Science Lynn.rochester@ncl.ac.uk http://research.ncl.ac.uk/hmst/ Purpose of Physiotherapy

More information

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019 WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019 YOUNG ONSET PARKINSON S DISEASE Definition: Parkinson s disease diagnosed

More information

Dr Barry Snow. Neurologist Auckland District Health Board

Dr Barry Snow. Neurologist Auckland District Health Board Dr Barry Snow Neurologist Auckland District Health Board Dystonia and Parkinson s disease Barry Snow Gowers 1888: Tetanoid chorea Dystonia a movement disorder characterized by sustained or intermittent

More information

Parkinson s Disease Foundation. Parkinson s Disease Foundation. PD ExpertBriefing: Led By: Ronald F. Pfeiffer, M.D. To hear the session live on:

Parkinson s Disease Foundation. Parkinson s Disease Foundation. PD ExpertBriefing: Led By: Ronald F. Pfeiffer, M.D. To hear the session live on: Parkinson s Disease Foundation Parkinson s Disease Foundation PD ExpertBriefing: Gait, Balance PD and ExpertBriefing: Falls in Parkinson s Disease Understanding Led By: the Terry Progression Ellis, Ph.D.,

More information

LINKING EVIDENCE AND PRACTICE. Physical Therapist Interventions for Parkinson Disease Robyn Gisbert, Margaret Schenkman

LINKING EVIDENCE AND PRACTICE. Physical Therapist Interventions for Parkinson Disease Robyn Gisbert, Margaret Schenkman Physical Therapist Interventions for Parkinson Disease Robyn Gisbert, Margaret Schenkman LEAP LINKING EVIDENCE AND PRACTICE highlights the findings and application of Cochrane reviews and other

More information

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain.

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain. Objectives Emerging Treatments in Parkinson s s Disease 1) Describe recent developments in the therapies for Parkinson s Disease Jeff Kraakevik MD Assistant Professor OHSU/Portland VAMC Parkinson s Center

More information

GBME graduate course. Chapter 43. The Basal Ganglia

GBME graduate course. Chapter 43. The Basal Ganglia GBME graduate course Chapter 43. The Basal Ganglia Basal ganglia in history Parkinson s disease Huntington s disease Parkinson s disease 1817 Parkinson's disease (PD) is a degenerative disorder of the

More information

Basal ganglia Sujata Sofat, class of 2009

Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Objectives Describe the function of the Basal Ganglia in movement Define the BG components and their locations Describe the motor loop of the BG

More information

Appendix N: Research recommendations

Appendix N: Research recommendations Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist

More information

Safinamide: un farmaco innovativo con un duplice meccanismo d azione

Safinamide: un farmaco innovativo con un duplice meccanismo d azione Safinamide: un farmaco innovativo con un duplice meccanismo d azione AINAT Sardegna Cagliari, 26 novembre 2016 Carlo Cattaneo Corporate Medical Advisor CNS & Rare Diseases Reichmann H. et al., European

More information

Parkinson's Disease KP Update

Parkinson's Disease KP Update Parkinson's Disease KP Update Andrew Imbus, PA-C Neurology, Movement Disorders Kaiser Permanente, Los Angeles Medical Center No disclosures "I often say now I don't have any choice whether or not I have

More information

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle Parkinson s Disease in the Elderly A Physicians perspective Dr John Coyle Overview Introduction Epidemiology and aetiology Pathogenesis Diagnosis and clinical features Treatment Psychological issues/ non

More information

The Shaking Palsy of 1817

The Shaking Palsy of 1817 The Shaking Palsy of 1817 A Treatment Update on Parkinson s Disease Dr Eitzaz Sadiq Neurologist CH Baragwanath Acadamic Hospital Parkinson s Disease O Premature death of dopaminergic neurons O Symptoms

More information

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE LEARNING OBJECTIVES The Course Participant will: 1. Be familiar with the pathogenesis of Parkinson s Disease (PD) 2. Understand clinical

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Review Article The Effectiveness of Physiotherapy Approaches in Patients with Parkinsonism Disease: A Saurabh Kumar 1,

More information

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD Joint Session with ACOFP and Mayo Clinic Parkinson's Disease: 5 Pearls Jay Van Gerpen, MD Parkinson s Disease: 5 Pearls J.A. van Gerpen, MD Sections of Movement Disorders and Clinical Neurophysiology

More information

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder Prevalence Parkinson s Disease Mark S. Baron, M.D. Associate Professor of Neurology Movement Disorders Section VCU School of Medicine Common disorder Approaching 1% by 65 yrs of age, 2% by 80 yrs of age

More information

Significance of Walking Speed. Maggie Benson Virginia Commonwealth University Department of Physical Therapy

Significance of Walking Speed. Maggie Benson Virginia Commonwealth University Department of Physical Therapy Significance of Walking Speed Maggie Benson Virginia Commonwealth University Department of Physical Therapy The 6 th Vital Sign Walking speed is considered the 6 th vital sign A valid and reliable measure

More information

Visualization and simulated animations of pathology and symptoms of Parkinson s disease

Visualization and simulated animations of pathology and symptoms of Parkinson s disease Visualization and simulated animations of pathology and symptoms of Parkinson s disease Prof. Yifan HAN Email: bctycan@ust.hk 1. Introduction 2. Biochemistry of Parkinson s disease 3. Course Design 4.

More information

NEUROPLASTICITY. Implications for rehabilitation. Genevieve Kennedy

NEUROPLASTICITY. Implications for rehabilitation. Genevieve Kennedy NEUROPLASTICITY Implications for rehabilitation Genevieve Kennedy Outline What is neuroplasticity? Evidence Impact on stroke recovery and rehabilitation Human brain Human brain is the most complex and

More information

PWR!Moves Instructor Training and Certification Workshop

PWR!Moves Instructor Training and Certification Workshop PWR!Moves Instructor Training and Certification Workshop Date December 8-9, 2018 Location Calgary Jewish Community Centre 1607 90 Ave SW Calgary AB T2V 4V7 Eligible Participants Certified Personal Trainers,

More information

Cognitive-Motor Interference in Persons with Parkinson Disease

Cognitive-Motor Interference in Persons with Parkinson Disease Cognitive-Motor Interference in Persons with Parkinson Disease Tara L. McIsaac, PhD, PT Associate Professor of Physical Therapy A.T. Still University Arizona School of Health Sciences October 11, 2014

More information

PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise

PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise Faculty: Becky G. Farley PT, MS, PhD & Jennifer Bazan-Wigle DPT Date April 9-10, 2016 Location Paso Robles,

More information

Optimizing Clinical Communication in Parkinson s Disease:

Optimizing Clinical Communication in Parkinson s Disease: Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of

More information

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN Parkinson s Academy Registrar Masterclass Sheffield DIFFERENTIAL DIAGNOSIS SARAH MARRINAN 17 th September 2014 Objectives Importance of age in diagnosis Diagnostic challenges Brain Bank criteria Differential

More information

Cheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy

Cheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy Cheyenne 11/28 Neurological Disorders II Transmissible Spongiform Encephalopathy -E.g Bovine4 Spongiform Encephalopathy (BSE= mad cow disease), Creutzfeldt-Jakob disease, scrapie (animal only) -Sporadic:

More information

Post-Polio Syndrome and Exercise Julie Simpson, PT Neuro and Cancer Rehab Programs St. Jude Centers for Rehabilitation and Wellness

Post-Polio Syndrome and Exercise Julie Simpson, PT Neuro and Cancer Rehab Programs St. Jude Centers for Rehabilitation and Wellness Post-Polio Syndrome and Exercise Julie Simpson, PT Neuro and Cancer Rehab Programs St. Jude Centers for Rehabilitation and Wellness The Therapy Gyms The Wellness Center CARF certified since 1976 Commission

More information

Mellen Center Approaches Exercise in MS

Mellen Center Approaches Exercise in MS Mellen Center Approaches Exercise in MS Framework: Physical exercise is generally recommended to promote fitness and wellness in individuals with or without chronic health conditions. Implementing and

More information

Movement Disorders: A Brief Overview

Movement Disorders: A Brief Overview Movement Disorders: A Brief Overview Albert Hung, MD, PhD Massachusetts General Hospital Harvard Medical School August 17, 2006 Cardinal Features of Parkinsonism Tremor Rigidity Bradykinesia Postural imbalance

More information

PARKINSON DISEASE DANCE FOR PD WORKSHOP

PARKINSON DISEASE DANCE FOR PD WORKSHOP PARKINSON DISEASE DANCE FOR PD WORKSHOP Heather Ene, MD A ssoci ate Professor Uni versi ty of Colorado Denver Departments of PMR and Neurology July 2011 Normal Motor Control Central Nervous System Premotor,

More information

Differential Diagnosis of Hypokinetic Movement Disorders

Differential Diagnosis of Hypokinetic Movement Disorders Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease

More information

Does the type of concurrent task affect preferred and cued gait in people with Parkinson s disease?

Does the type of concurrent task affect preferred and cued gait in people with Parkinson s disease? Does the type of concurrent task affect preferred and cued gait in people with Parkinson s disease? Robyn Galletly 1 and Sandra G Brauer 1, 2 1 Division of Physiotherapy, University of Queensland 2 Department

More information

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements BASAL GANGLIA Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University at Buffalo I) Overview How do Basal Ganglia affect movement Basal ganglia enhance cortical motor activity and facilitate movement.

More information

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B.

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. UvA-DARE (Digital Academic Repository) Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. Link to publication Citation for published version (APA): Post, B. (2009). Clinimetrics,

More information

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness

More information

The Effect of Weighted Compression Sleeves on Tremor Suppression in Individuals with Parkinson s Disease

The Effect of Weighted Compression Sleeves on Tremor Suppression in Individuals with Parkinson s Disease The Effect of Weighted Compression Sleeves on Tremor Suppression in Individuals with Parkinson s Disease Jennifer Iannello, Garry Johnson, Lauren Pilla Parkinson s Disease Second most common chronic, progressive,

More information

QUALE RIABILITAZIONE NEL FUTURO PER LA MALATTIA DI PARKINSON?

QUALE RIABILITAZIONE NEL FUTURO PER LA MALATTIA DI PARKINSON? QUALE RIABILITAZIONE NEL FUTURO PER LA MALATTIA DI PARKINSON? DANIELE VOLPE Casa di Cura Villa Margherita Vicenza GVDR Padova Evidence: Systematic Reviews Rapidly emerging research literature on physio

More information

Chinese Proverb. He who asks a question is a fool for five minutes; he who does not ask a question remains a fool forever. What do we Fix?

Chinese Proverb. He who asks a question is a fool for five minutes; he who does not ask a question remains a fool forever. What do we Fix? Robert H. Rowe, PT, DPT, DMT, MHS, FAAOMPT Director Brooks Institute of Higher Learning Chinese Proverb He who asks a question is a fool for five minutes; he who does not ask a question remains a fool

More information

UNDERSTANDING PARKINSON S DISEASE

UNDERSTANDING PARKINSON S DISEASE UNDERSTANDING PARKINSON S DISEASE WHAT IS PARKINSON S DISEASE? A progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement, chiefly affecting middleaged

More information

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging Dr. Olav E. Krigolson krigolson@uvic.ca Lecture 5: PARKINSONS DISEASE The Basal Ganglia Primary motor cortex Execution of movement

More information

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits

More information

Does Exercise Reduce the Risk of Falling in Parkinson s Patients?

Does Exercise Reduce the Risk of Falling in Parkinson s Patients? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Does Exercise Reduce the Risk of Falling

More information

European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations

European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations July 6, 2016 European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations Porto, 5 July 2016 BIAL announced that the medicinal product ONGENTYS

More information

PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise

PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise PWR!Moves Instructor Training and Certification Workshop Train Amplitude and Make FUNction Exercise Date January 6-7, 2018 Location The Parkinson s Fitness Project 106 Lakeside Ave Seattle, WA 98122 Target

More information

Making Things Happen 2: Motor Disorders

Making Things Happen 2: Motor Disorders Making Things Happen 2: Motor Disorders How Your Brain Works Prof. Jan Schnupp wschnupp@cityu.edu.hk HowYourBrainWorks.net On the Menu in This Lecture In the previous lecture we saw how motor cortex and

More information

Exercising with Persistent Pain

Exercising with Persistent Pain Exercising with Persistent Pain Why You Feel Pain When you are injured, your mind and body react. They protect the weak part of your body, and you feel pain when you try to use it. This protection is important

More information

Faints, Fits, Funny Turns. Andrew Clements

Faints, Fits, Funny Turns. Andrew Clements Faints, Fits, Funny Turns Andrew Clements Royal College of Physicians Bristol January 18 th 2016 Faints, Fits & Funny Turns for the Physician Physiotherapy in the management of imbalance Andrew Clements

More information

Parts of the motor circuits

Parts of the motor circuits MOVEMENT DISORDERS Parts of the motor circuits cortical centers: there are centers in all the cortical lobes subcortical centers: caudate nucleus putamen pallidum subthalamical nucleus (Luys) nucleus ruber

More information

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following: 1 PARKINSON S DISEASE Parkinson's disease is a long term disease related to the central nervous system that mainly affects the motor system, resulting in the loss of dopamine, which helps in producing

More information

Study protocol. Resistance versus Balance Training to improve postural control in Parkinson s disease

Study protocol. Resistance versus Balance Training to improve postural control in Parkinson s disease Study protocol (English translation of the german study protocol; for the complete study protocol see german version) Resistance versus Balance Training to improve postural control in Parkinson s disease

More information

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease Making Every Little Bit Count: Parkinson s Disease SHP Neurobiology of Development and Disease Parkinson s Disease Initially described symptomatically by Dr. James Parkinson in 1817 in An Essay on the

More information

Surgical Management of Parkinson s Disease

Surgical Management of Parkinson s Disease Surgical Management of Parkinson s Disease Shyamal H. Mehta MD, PhD Assistant Professor of Neurology, Movement Disorders Division Mayo Clinic College of Medicine Mayo Clinic, Arizona 2016 MFMER slide-1

More information

Population: People diagnosed with idiopathic Parkinson s disease in the early stages of the disease who have not yet had a fall.

Population: People diagnosed with idiopathic Parkinson s disease in the early stages of the disease who have not yet had a fall. PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation projects. QUESTION

More information

Dance for Parkinson s disease. Laurie King, PT, PhD Dept. of Neurology Oregon Health & Science University Portland, OR

Dance for Parkinson s disease. Laurie King, PT, PhD Dept. of Neurology Oregon Health & Science University Portland, OR Dance for Parkinson s disease Laurie King, PT, PhD Dept. of Neurology Oregon Health & Science University Portland, OR Studies of effects of exercise in PD on are on the rise sell lag behind other types

More information

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd. Scottish Medicines Consortium Re-Submission rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd 10 November 2006 The Scottish Medicines Consortium (SMC) has completed

More information

Part I Parkinson Disease Diagnosis and Treatment

Part I Parkinson Disease Diagnosis and Treatment Part I Parkinson Disease Diagnosis and Treatment Parkinson Disease A Health Policy Perspective. Edited by Wayne Martin, Oksana Suchowersky, Katharina Kovacs Burns, and Egon Jonsson Copyright 2010 WILEY-VCH

More information

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai Parkinson s disease Therapeutic strategies Surat Tanprawate, MD Division of Neurology University of Chiang Mai 1 Scope Modality of treatment Pathophysiology of PD and dopamine metabolism Drugs Are there

More information

Update on Parkinson s disease and other Movement Disorders October 2018

Update on Parkinson s disease and other Movement Disorders October 2018 Update on Parkinson s disease and other Movement Disorders October 2018 DR. JONATHAN EVANS CONSULTANT IN NEUROLOGY QUEEN S MEDICAL CENTRE NOTTINGHAM Disclosures: Honoraria UCB, Britannia, Allergan, AbbVie

More information

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Chapter 8 Parkinsonism M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Definition of Parkinson s Disease Parkinson's disease is a progressive, neurodegenerative disease

More information

THIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY?

THIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY? THIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY? THURSDAY MARCH 14, 2019 REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA AMERICAN

More information

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff USE OF HUMAN EMBRYONIC STEM CELLS IN THE TREATMENT OF PARKINSON S DISEASE Dr. Geeta Shroff Founder and Medical Director, Nutech Mediworld CONDITIONS TREATED Spinal Cord Injury Cell Culture Technology Diabetes

More information

The PD You Don t See: Cognitive Symptoms. Joanne M. Hamilton, PhD, ABPP Clinical Neuropsychologist Division of Neurology Scripps Health

The PD You Don t See: Cognitive Symptoms. Joanne M. Hamilton, PhD, ABPP Clinical Neuropsychologist Division of Neurology Scripps Health The PD You Don t See: Cognitive Symptoms Joanne M. Hamilton, PhD, ABPP Clinical Neuropsychologist Division of Neurology Scripps Health OBJECTIVES To understand why cognitive changes occur in a motor disease

More information

The Marmoset Monkey as Model for Neurological Disorders

The Marmoset Monkey as Model for Neurological Disorders The Marmoset Monkey as Model for Neurological Disorders Jan Langermans and Ingrid Philippens From Laboratory to Clinic Disease models neuroscience: Parkinson, Sleep, Stress, Alzheimer, MS MS Models: rhmog

More information